Anti-CD44-monoclonal-antibody-KM81

N/A

Report date: 2022/08/24 20:00:31

Base Information

Drug NameAnti-CD44-monoclonal-antibody-KM81
Drug Alias NameKM81
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCD44 antigen inhibitors
TargetsCD44 antigen
Therapy Area/IndicationsGraft vs Host DiseaseArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A